Mental health support across the sight loss pathway: a qualitative exploration of eye care patients, optometrists, and ECLOs.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
08 2023
Historique:
received: 06 05 2022
accepted: 16 12 2022
revised: 29 11 2022
medline: 4 8 2023
pubmed: 11 1 2023
entrez: 10 1 2023
Statut: ppublish

Résumé

The process of becoming visually impaired or blind is undoubtedly a highly emotional experience, requiring practical and psychological support. Information on mental health support provision in the UK across the sight-loss pathway, however, is largely unknown, especially amongst healthcare practitioners that are often sought after for advice: the referring optometrist and eye clinic liaison officer (ECLO). This study aims to ascertain the perceived accessibility and quality of mental health support across the sight-loss pathway. Semi-structured individual interviews were conducted with patients with a diagnosed eye condition who had received care from a hospital eye service, referring optometrists, and ECLOs. Following interview transcription, results were synthesised in a narrative analysis. A total of 28 participants were included in the analysis, of which 17 were participants with various eye conditions, five were referring optometrists, and five were ECLOs. After analysis, three broad themes emerged: (1) The emotional trauma of diagnosis (2) Availability of mental health support; (3) The point where mental health support is most needed across the sight-loss pathway. Several patients reporting that they had received no offer of support nor were they signposted to any possible sources. Referring optometrists and ECLO's agreed. It is important that referring optometrists are aware of the need for mental health support services and can signpost to local support services including the third sector anytime during the referral process. Future large-scale, UK-wide research into referral practice and signposting for mental health support for patients is warranted, to identify how services can be improved in order to ensure that the wellbeing of patients is maintained.

Sections du résumé

BACKGROUND
The process of becoming visually impaired or blind is undoubtedly a highly emotional experience, requiring practical and psychological support. Information on mental health support provision in the UK across the sight-loss pathway, however, is largely unknown, especially amongst healthcare practitioners that are often sought after for advice: the referring optometrist and eye clinic liaison officer (ECLO). This study aims to ascertain the perceived accessibility and quality of mental health support across the sight-loss pathway.
METHODS
Semi-structured individual interviews were conducted with patients with a diagnosed eye condition who had received care from a hospital eye service, referring optometrists, and ECLOs. Following interview transcription, results were synthesised in a narrative analysis.
RESULTS
A total of 28 participants were included in the analysis, of which 17 were participants with various eye conditions, five were referring optometrists, and five were ECLOs. After analysis, three broad themes emerged: (1) The emotional trauma of diagnosis (2) Availability of mental health support; (3) The point where mental health support is most needed across the sight-loss pathway. Several patients reporting that they had received no offer of support nor were they signposted to any possible sources. Referring optometrists and ECLO's agreed.
CONCLUSION
It is important that referring optometrists are aware of the need for mental health support services and can signpost to local support services including the third sector anytime during the referral process. Future large-scale, UK-wide research into referral practice and signposting for mental health support for patients is warranted, to identify how services can be improved in order to ensure that the wellbeing of patients is maintained.

Identifiants

pubmed: 36627444
doi: 10.1038/s41433-022-02373-z
pii: 10.1038/s41433-022-02373-z
pmc: PMC10397192
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2554-2558

Informations de copyright

© 2023. The Author(s).

Références

BMJ Open. 2016 May 18;6(5):e010952
pubmed: 27194319
Int J Environ Res Public Health. 2018 Jan 19;15(1):
pubmed: 29351207
Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1307-1313
pubmed: 34633521
Front Psychol. 2021 Jan 18;11:627980
pubmed: 33536989
Int J Geriatr Psychiatry. 2021 Sep;36(9):1378-1385
pubmed: 33694200
BMJ Open Ophthalmol. 2020 Dec 29;5(1):e000587
pubmed: 33437871
BMJ Open Ophthalmol. 2020 Jun 2;5(1):e000437
pubmed: 32885049
Eye (Lond). 2010 Nov;24(11):1692-9
pubmed: 20847749
Child Care Health Dev. 2015 Mar;41(2):239-48
pubmed: 24913734
Lancet Glob Health. 2021 Feb;9(2):e130-e143
pubmed: 33275950
Front Neurosci. 2022 Jan 27;16:786244
pubmed: 35153667
BMJ Open. 2014 Dec 15;4(12):e005498
pubmed: 25510885
Front Public Health. 2021 Dec 07;9:769155
pubmed: 34950629
Ophthalmol Ther. 2020 Jun;9(2):215-220
pubmed: 32200476
Int J Environ Res Public Health. 2022 Mar 11;19(6):
pubmed: 35328994
Int J Environ Res Public Health. 2022 Jan 06;19(2):
pubmed: 35055443

Auteurs

M Trott (M)

Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK. mike.trott@aru.ac.uk.
Centre for Public Health, Queen's University Belfast, Belfast, UK. mike.trott@aru.ac.uk.

R Driscoll (R)

Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK.

R Bourne (R)

Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK.

J Slade (J)

Royal National Institute of Blind People, London, UK.

H Ingleton (H)

Royal National Institute of Blind People, London, UK.

S Farrell (S)

Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.

M Bowen (M)

College of Optometrists, London, UK.

R Lovell-Patel (R)

NHS England and NHS Improvement, London, UK.

J Kidd (J)

Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK.

S Pardhan (S)

Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH